By Super Admin

Seeking Alpha / Seaking Alpha - 16 hours ago

Asieris Pharmaceuticals Unveils 2023 Annual Report, Core Product APL-1702 Succeeds in Global Phase III Clinical Trials, APL-1706 obtains NDA acceptance domestically, Specialty Commercial Team Generates Sustained Revenue Streams

SHANGHAI, April 17, 2024 /PRNewswire/ -- Asieris Pharmaceuticals today released its 2023 Annual Report, revealing impressive outcomes achieved through its specialty pharma strategy, which has facilitated rapid progress in clinical development, early research, and commercialization....

Seeking Alpha / Seaking Alpha - 16 hours ago

Scrumptious Ways to Simplify Springtime Meals

Make weekday dining a breeze with easy, delicious recipes MISSION, Kan., April 17, 2024 /PRNewswire/ -- (Family Features) From everyday weeknight dinners to picnics in the park, warmer weather and longer days mean families want to spend more time together and less time in the kitchen....